Literature DB >> 7036531

A new elution procedure using chloroform, a nonflammable organic solvent.

D R Branch, A L Hian, L D Petz.   

Abstract

A new method for eluting red cell antibodies using chloroform has been shown to be effective. The method is similar to ether and xylene techniques but can be completed within 10 min after adequate cell washing. Comparison studies using ether, xylene and chloroform showed that antibodies eluted by chloroform yielded equivalent titration scores. Antibodies within the Ss blood group system were easily eluted using chloroform but not using ether. Also, the chloroform method yielded informative eluates when prepared from red cells of patients with warm antibody autoimmune hemolytic anemia, drug-induced immune hemolytic anemia, hemolytic disease of the newborn caused by ABO or Rh fetal maternal incompatibility, or from patients having a positive direct antiglobulin test as a result of alloantibodies stimulated by recent transfusion ("delayed transfusion reaction'). The advantages of chloroform elution are: (1) chloroform is nonflammable; (2) the eluate is readily obtained from the top layer after centrifugation; (3) no residual solvent remains in the eluate, and (4) the method is rapid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036531     DOI: 10.1111/j.1423-0410.1982.tb01068.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  An unusual sample of irregular anti-A1, probably causing an early delayed transfusion reaction.

Authors:  H Northoff; A Wölpl; U Sugg; W Junginger; J Meinke; J Welter; W Schneider
Journal:  Blut       Date:  1986-05

2.  Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.

Authors:  D J Christie; P C Mullen; R H Aster
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

3.  Elution of antispectrin antibodies from red cells in homozygous beta-thalassaemia.

Authors:  E Wiener; N C Hughes-Jones; W T Irish; S N Wickramasinghe
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.